Home » Newsletters » BioWorld Asia

BioWorld Asia

July 11, 2001

View Archived Issues

Inpharmaticas $44M Round Will Help Move Compounds Forward

French Biotech Industry Calls For $3.4 Billion In State Support

Ichor Raises $2M To Develop Novel AIDS Therapies, Vaccines

EBE Weighs In As Biotechnology Firms Await Authorization Rules

Amedis Completes First Funding Round For Drug Selection Work

Sterix Raises #8M To Fund Steroid Metabolism Program

Other News To Note

PowderJect To Sell Needle-Free Technology In Restructuring

Micromet, Curis Collaborate In Areas Of Antibodies, Stem Cells

MorphoSys Faces New Lawsuit; CATs Filing On Patent Dismissed

Cell Proliferation Finding Backed By Drug Discovery Strategy

Active Biotech Narrows Focus To Drugs After Vaccine Unit Sale

Ethicist Says Human Clones Are Ticking Time Bomb In Europe

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 31, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026